Conversion of Dexerials Hong Kong Limited into a joint venture
First written in FY2024-Q3. 1 of 2 entries say "Achieved", first in FY2025-H1. Latest entry: FY2025-H1.
6 other companies' latest entry also says "Achieved".
- FY2025-H1AchievedAnnual report
「In connection with the share transfer dated 1 July 2024 under the agreements, Dexerials Hong Kong Limited was removed from the company’s consolidated subsidiaries and became an equity-method affiliate. On the same date, the company changed its corporate name to Restar Dexerials Hong Kong Limited.」
The transfer of shares in Dexerials Hong Kong Limited was completed on 1 July 2024, and the company changed from a consolidated subsidiary to an equity-method affiliate. - FY2024-Q3First statedAnnual report
「At a meeting of the Board of Directors held on 5 February 2024, the company resolved to enter into a share transfer agreement and shareholders’ agreement for the purpose of converting Dexerials Hong Kong Limited into a joint venture, and entered into those agreements with Restar Holdings Corporation.」
The company decided to transfer 51% of the shares in its Hong Kong sales subsidiary and make it an equity-method affiliate in which it would retain a 49% interest, in order to improve the efficiency of sales operations in Asia through cooperation with Restar Holdings Corporation. The transfer closing date and business start date were scheduled for 1 July 2024.